A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01155362
Recruitment Status : Completed
First Posted : July 1, 2010
Last Update Posted : March 2, 2018
Celgene Corporation
Information provided by (Responsible Party):
Celularity Incorporated

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : April 2014
  Certification/Extension First Submitted : August 7, 2013